These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 15149624)

  • 41. High-throughput multiplexed capillary electrophoresis in drug discovery.
    Pang HM; Kenseth J; Coldiron S
    Drug Discov Today; 2004 Dec; 9(24):1072-80. PubMed ID: 15582796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of microwave synthesis on drug discovery.
    Kappe CO; Dallinger D
    Nat Rev Drug Discov; 2006 Jan; 5(1):51-63. PubMed ID: 16374514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hit and Lead identification: efficient practices for drug discovery.
    Goodnow RA; Gillespie P
    Prog Med Chem; 2007; 45():1-61. PubMed ID: 17280901
    [No Abstract]   [Full Text] [Related]  

  • 44. Solid form screening--a review.
    Aaltonen J; Allesø M; Mirza S; Koradia V; Gordon KC; Rantanen J
    Eur J Pharm Biopharm; 2009 Jan; 71(1):23-37. PubMed ID: 18715549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Solid-phase strategies for the design and synthesis of heterocyclic molecules of medicinal interest.
    Kundu B
    Curr Opin Drug Discov Devel; 2003 Nov; 6(6):815-26. PubMed ID: 14758753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of structural diversity in combinatorial synthesis.
    Fergus S; Bender A; Spring DR
    Curr Opin Chem Biol; 2005 Jun; 9(3):304-9. PubMed ID: 15939333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enabling high-throughput discovery.
    Vaschetto M; Weissbrod T; Bodle D; Güner O
    Curr Opin Drug Discov Devel; 2003 May; 6(3):377-83. PubMed ID: 12833671
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Scientific workflows as productivity tools for drug discovery.
    Shon J; Ohkawa H; Hammer J
    Curr Opin Drug Discov Devel; 2008 May; 11(3):381-8. PubMed ID: 18428092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel fluorescent proteins for high-content screening.
    Wolff M; Wiedenmann J; Nienhaus GU; Valler M; Heilker R
    Drug Discov Today; 2006 Dec; 11(23-24):1054-60. PubMed ID: 17129823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modern natural products chemistry and drug discovery.
    Ojima I
    J Med Chem; 2008 May; 51(9):2587-8. PubMed ID: 18393400
    [No Abstract]   [Full Text] [Related]  

  • 52. Applications of self-organizing neural networks in virtual screening and diversity selection.
    Selzer P; Ertl P
    J Chem Inf Model; 2006; 46(6):2319-23. PubMed ID: 17125175
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statistical methods for estimating complexity from competition experiments between two populations.
    Montgomery-Smith SJ; Schmidt FJ
    J Theor Biol; 2010 Jun; 264(3):1043-6. PubMed ID: 20211634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug discovery and natural products: end of an era or an endless frontier?
    Li JW; Vederas JC
    Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A screening study of ChirBase molecular database to explore the expanded chiral pool derived from the application of chiral chromatography.
    Piras P; Roussel C
    J Pharm Biomed Anal; 2008 Apr; 46(5):839-47. PubMed ID: 17942261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combinatorial approaches to formulation development.
    Alakhov V; Pietrzynski G; Kabanov A
    Curr Opin Drug Discov Devel; 2001 Jul; 4(4):493-501. PubMed ID: 11727314
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Statistical practice in high-throughput screening data analysis.
    Malo N; Hanley JA; Cerquozzi S; Pelletier J; Nadon R
    Nat Biotechnol; 2006 Feb; 24(2):167-75. PubMed ID: 16465162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
    Srinivas NR
    Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The multiple orthogonal tools approach to define molecular causation in the validation of druggable targets.
    Hardy LW; Peet NP
    Drug Discov Today; 2004 Feb; 9(3):117-26. PubMed ID: 14960389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.